{"entity":{"type":"insider","cik":"0001518724","url":"/insider/0001518724","json_url":"/insider/0001518724.json","name":"Jensen Peder","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2011-05-16","last":"2016-11-10","span_basis":"filed_date"},"name_variants":[{"name":"Jensen Peder","source":"filing","n_filings":6,"first_seen":"2011-05-16","last_seen":"2016-11-10"}],"transactions":[{"id":2378821,"accession":"0001209191-16-149265","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-149265","line_url":"/filing/0001209191-16-149265#line-3","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001518724","owner_name":"Jensen Peder","owner_display_name":"Jensen Peder","owner_url":"/insider/0001518724","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8130.0,"shares_display":"8,130","price_per_share":55.3,"price_display":"55.30","price_state":"stated","total_value":449589.0,"total_display":"449,589.00","total_whole":"449,589","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-09","filed_date":"2016-11-10","scope":"insider"},{"id":2551099,"accession":"0001209191-16-134219","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-134219","line_url":"/filing/0001209191-16-134219#line-2","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001518724","owner_name":"Jensen Peder","owner_display_name":"Jensen Peder","owner_url":"/insider/0001518724","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12195.0,"shares_display":"12,195","price_per_share":49.5,"price_display":"49.50","price_state":"stated","total_value":603652.5,"total_display":"603,652.50","total_whole":"603,653","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-27","filed_date":"2016-07-28","scope":"insider"},{"id":3493456,"accession":"0001127602-12-034080","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-12-034080","line_url":"/filing/0001127602-12-034080#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001518724","owner_name":"Jensen Peder","owner_display_name":"Jensen Peder","owner_url":"/insider/0001518724","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.51,"price_display":"1.51","price_state":"stated","total_value":30200.0,"total_display":"30,200.00","total_whole":"30,200","shares_owned_after":60000.0,"shares_owned_after_display":"60,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-14","filed_date":"2012-12-17","scope":"insider"},{"id":2288272,"accession":"0001127602-12-019433","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-12-019433","line_url":"/filing/0001127602-12-019433#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001518724","owner_name":"Jensen Peder","owner_display_name":"Jensen Peder","owner_url":"/insider/0001518724","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":3.184,"price_display":"3.18","price_state":"stated","total_value":63680.0,"total_display":"63,680.00","total_whole":"63,680","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-05","filed_date":"2012-06-05","scope":"insider"},{"id":9051304,"accession":"0001127602-11-030111","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-11-030111","line_url":"/filing/0001127602-11-030111#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001518724","owner_name":"Jensen Peder","owner_display_name":"Jensen Peder","owner_url":"/insider/0001518724","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":27500.0,"total_display":"27,500.00","total_whole":"27,500","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-18","filed_date":"2011-11-18","scope":"insider"},{"id":9138588,"accession":"0001127602-11-016473","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-11-016473","line_url":"/filing/0001127602-11-016473#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001518724","owner_name":"Jensen Peder","owner_display_name":"Jensen Peder","owner_url":"/insider/0001518724","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.56,"price_display":"3.56","price_state":"stated","total_value":35600.0,"total_display":"35,600.00","total_whole":"35,600","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-12","filed_date":"2011-05-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001175505","name":"FIVE PRIME THERAPEUTICS INC","url":"/issuer/0001175505","role":"Director","n_filings":2,"first_seen":"2016-07-28","last_seen":"2016-11-10"},{"type":"issuer","type_label":"ISSUER","cik":"0000882796","name":"BIOCRYST PHARMACEUTICALS INC","url":"/issuer/0000882796","role":"Director","n_filings":4,"first_seen":"2011-05-16","last_seen":"2012-12-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001518724","retrieved_at":"2026-08-25T15:06:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}